Fingernail‐based Metabolomics Reveals a Stepwise Decline in Dodecanoic Acid Associated with Alzheimer's Disease Progression

Abstract

Background: Fingernail metabolomics provides a novel, non‐invasive platform that captures long‐term biochemical fluctuations for identifying reliable biomarkers for dementia and mild cognitive impairment (MCI) due to Alzheimer's disease (AD).

The paper